Tacrolimus
NDC 82983-401, Tacrolimus, capsule, from Ajenat Pharmaceuticals LLC.
- Product NDC
- 82983-401
- Status
- Listed
- Labeler
- Ajenat Pharmaceuticals LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206651
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82983-401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TACROLIMUS1 mg/1
Pharmacologic classes
Calcineurin Inhibitor Immunosuppressant [EPC]; Calcineurin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82983-401-10 | 82983040110 | 100 CAPSULE in 1 BOTTLE (82983-401-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ca08d4aa-3de2-4a9d-9554-6288e5d36f29
Use it
Look up 82983-401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82983-401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82983-401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.